iTNT
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases (NCT06850103) | First Affiliated Hospital of Zhejiang University | 2025-04-22 |
Track iTNT automatically
Every clearance here is in the API, with alerts when new ones post.